Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placebo or one of two doses of subcutaneous immunoglobul...

Full description

Saved in:
Bibliographic Details
Published in:J Peripher Nerv Syst
Main Authors: Lewis, Richard A., Cornblath, David R., Hartung, Hans‐Peter, Sobue, Gens, Lawo, John‐Philip, Mielke, Orell, Durn, Billie L., Bril, Vera, Merkies, Ingemar S. J., Bassett, Paul, Cleasby, Alexa, van Schaik, Ivo N.
Format: Artigo
Language:Inglês
Published: Wiley Periodicals, Inc. 2020
Subjects:
Research Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497019/
https://ncbi.nlm.nih.gov/pubmed/32627277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12402
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items